Fenton Pharmaceuticals Ltd
02808198
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/10/2025
total exemption full
Next accounts due
31/07/2027
Confirmation statement
Last: 25/06/2026
Due 09/07/2027
Industry
Officers
director · Since 26/06/2024
DIRECTOR
BRITISH · UNITED KINGDOM · Age 59
Also on 1 other board
Persons with Significant Control
Mr Graham Alexander Fenton Hill
British · United Kingdom · Age 63
Fenton House, 4 Hampstead Gate, London, NW3 6AL
Notified 06/04/2016
Mr Richard Charles Worts
British · United Kingdom · Age 72
7, Spencer Place, London, N1 2AX
Notified 09/10/2018
CompanyRankvs 42+ SIC 21200 peers79
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/10/2025
Net Worth
£7.1M
Balance sheet strength
Cash
£2.6M
Cash in the bank
Net Current Assets
£2.0M
Working capital
Current Assets
£7.8M
Current Liabilities
£5.8M
Fixed Assets
£5.1M
Debtors
£4.7M
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 1.34 | +£0 | £3.9M |
| 2025 | 1.34 | +£596k | £3.9M |
| 2024 | 2.12 | +£988k | £9.1M |
| 2023 | 3.08 | — | £4.5M |
Derived from filed accounts. Not audited figures.